0:00
11:00
@ michaelsalzle Patients with diabetes and chronic disease are at high risk for kidney failure, cardiovascular events, and death. The FLOW trial looked at the safety and efficacy of semaglutide in patients with chronic disease and type 2 diabetes.
Weitere Episoden von „Healthspan“
Verpasse keine Episode von “Healthspan” und abonniere ihn in der kostenlosen GetPodcast App.